日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological Factors

慢性瘙痒中的灾难化思维:与人口统计学、临床和心理因素的关联

Niemeyer, Isabel; Salameh, Pascale; Linß, Hanna H; Grekowitz, Eva M; Herzog, Leonie S; Metz, Martin; Pereira, Manuel P

Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial

使用伊祖福兰(LEO 152020)靶向组胺受体 4 治疗胆碱能性荨麻疹:一项 IIa 期随机双盲安慰剂对照多中心交叉试验的结果

Grekowitz, Eva; Metz, Martin; Altrichter, Sabine; Bauer, Andrea; Brockow, Knut; Heine, Guido; Lionnet, Leonard; Saday, Kadriye Kaplan; Hultsch, Thomas; Søerensen, Ole E; Maurer, Marcus

Evidence for histamine release in chronic inducible urticaria - A systematic review

慢性诱发性荨麻疹中组胺释放的证据——系统性综述

Kulthanan, Kanokvalai; Church, Martin K; Grekowitz, Eva Maria; Hawro, Tomasz; Kiefer, Lea Alice; Munprom, Kanyalak; Nanchaipruek, Yanisorn; Rujitharanawong, Chuda; Terhorst-Molawi, Dorothea; Maurer, Marcus

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries

德语国家胆碱能性荨麻疹患者的疾病影响、诊断延误和未满足的医疗需求

Altrichter, Sabine; Mellerowicz, Emilia; Terhorst-Molawi, Dorothea; Grekowitz, Eva; Weller, Karsten; Maurer, Marcus

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab

巴瑞替尼可快速且持续地缓解对度普利尤单抗治疗无效的病因不明的慢性瘙痒症患者。

Buttgereit, Thomas; Grekowitz, Eva Maria; Metz, Martin